The epigenetic mechanism of metabolic risk in bipolar disorder

被引:0
|
作者
Huang, Kexin [1 ]
Li, Sujuan [1 ]
Yang, Min [1 ]
Teng, Ziwei [1 ]
Xu, Baoyan [1 ,2 ]
Wang, Bolun [3 ]
Chen, Jindong [1 ]
Zhao, Liping [4 ]
Wu, Haishan [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, China Natl Technol Inst Mental Disorders, Dept Psychiat,Natl Clin Res Ctr Mental Disorders, Changsha 410011, Hunan, Peoples R China
[2] Hebei Univ, Clin Med Coll 6, Hebei Prov Mental Hlth Ctr, Hebei Key Lab Major Mental & Behav Disorders,Dept, Baoding, Hebei, Peoples R China
[3] Cent South Univ, Second Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China
[4] Cent South Univ, Second Xiangya Hosp, Clin Nursing Teaching & Res Sect, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
bipolar disorder; epigenetics; metabolic syndrome; DNA METHYLATION; INSULIN-RESISTANCE; MOOD STABILIZERS; LIPID-METABOLISM; SCHIZOPHRENIA; EXPRESSION; ASSOCIATION; ANTIPSYCHOTICS; DYSREGULATION; CLOCK;
D O I
10.1111/obr.13816
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bipolar disorder (BD) is a complex and severe mental illness that causes significant suffering to patients. In addition to the burden of depressive and manic symptoms, patients with BD are at an increased risk for metabolic syndrome (MetS). MetS includes factors associated with an increased risk of atherosclerotic cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), which may increase the mortality rate of patients with BD. Several studies have suggested a link between BD and MetS, which may be explained at an epigenetic level. We have focused on epigenetic mechanisms to review the causes of metabolic risk in BD.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Neurobiology of Risk for Bipolar Disorder
    Özerdem A.
    Ceylan D.
    Can G.
    Current Treatment Options in Psychiatry, 2016, 3 (4) : 315 - 329
  • [42] The risk for schizophrenia and bipolar disorder in siblings of probands with schizophrenia and bipolar disorder
    Ösby, U
    Brandt, L
    Terenius, L
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 24 - 24
  • [43] Neural Markers in Pediatric Bipolar Disorder and Familial Risk for Bipolar Disorder
    Wiggins, Jillian Lee
    Brotman, Melissa A.
    Adleman, Nancy E.
    Kim, Pilyoung
    Wambach, Caroline G.
    Reynolds, Richard C.
    Chen, Gang
    Towbin, Kenneth
    Pine, Daniel S.
    Leibenluft, Ellen
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (01): : 67 - 78
  • [44] SUICIDAL RISK IN BIPOLAR DISORDER
    Tondo, Leonardo
    Baldessarini, Ross
    CLINICAL NEUROPSYCHIATRY, 2005, 2 (01): : 55 - 65
  • [45] The risk for schizophrenia and bipolar disorder in siblings to probands with schizophrenia and bipolar disorder
    Ösby, U
    Brandt, L
    Terenius, L
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 579 - 579
  • [46] Could metabolic syndrome comorbidity in bipolar disorder be overrated?: a study of metabolic syndrome in young subpopulation of bipolar disorder patients
    Yalin, N.
    Agdanli, O. U.
    Ergor, G.
    Tunca, Z.
    Vitoratou, S.
    Ozerdem, A.
    BIPOLAR DISORDERS, 2014, 16 : 80 - 80
  • [47] A cross sectional study to estimate cardiovascular and metabolic risk factors in patients with bipolar disorder
    Damegunta, S.
    Rao, G. Prasad
    BIPOLAR DISORDERS, 2014, 16 : 111 - 112
  • [48] High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder
    Salvi, Virginio
    Barone-Adesi, Francesco
    D'Ambrosio, Virginia
    Albert, Umberto
    Maina, Giuseppe
    PSYCHOPHARMACOLOGY, 2016, 233 (01) : 49 - 56
  • [49] High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder
    Virginio Salvi
    Francesco Barone-Adesi
    Virginia D’Ambrosio
    Umberto Albert
    Giuseppe Maina
    Psychopharmacology, 2016, 233 : 49 - 56
  • [50] The mechanism of action of psychoeducation in bipolar disorder
    Vieta, E
    Colom, F
    BIPOLAR DISORDERS, 2004, 6 : 18 - 18